- Home
- BWEN vs APLT Comparison
BWEN vs APLT Comparison
Compare BWEN & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- APLT
- Stock Information
- Founded
- BWEN N/A
- APLT 2016
- Country
- BWEN United States
- APLT United States
- Employees
- BWEN N/A
- APLT N/A
- Industry
- BWEN Industrial Machinery/Components
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- BWEN Industrials
- APLT Health Care
- Exchange
- BWEN Nasdaq
- APLT Nasdaq
- Market Cap
- BWEN 41.1M
- APLT 44.0M
- IPO Year
- BWEN N/A
- APLT 2019
- Fundamental
- Price
- BWEN $1.85
- APLT $0.41
- Analyst Decision
- BWEN Strong Buy
- APLT Buy
- Analyst Count
- BWEN 3
- APLT 7
- Target Price
- BWEN $4.50
- APLT $6.10
- AVG Volume (30 Days)
- BWEN 78.8K
- APLT 2.6M
- Earning Date
- BWEN 08-12-2025
- APLT 08-06-2025
- Dividend Yield
- BWEN N/A
- APLT N/A
- EPS Growth
- BWEN N/A
- APLT N/A
- EPS
- BWEN N/A
- APLT N/A
- Revenue
- BWEN $142,358,000.00
- APLT $265,000.00
- Revenue This Year
- BWEN $7.86
- APLT $1,768.13
- Revenue Next Year
- BWEN $4.51
- APLT $292.85
- P/E Ratio
- BWEN N/A
- APLT N/A
- Revenue Growth
- BWEN N/A
- APLT N/A
- 52 Week Low
- BWEN $1.41
- APLT $0.30
- 52 Week High
- BWEN $3.69
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- BWEN 53.16
- APLT 58.87
- Support Level
- BWEN $1.77
- APLT $0.32
- Resistance Level
- BWEN $1.96
- APLT $0.36
- Average True Range (ATR)
- BWEN 0.07
- APLT 0.04
- MACD
- BWEN -0.00
- APLT 0.01
- Stochastic Oscillator
- BWEN 52.17
- APLT 94.92
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.